Skip to content

Norris Industries, Inc.: 10-Q filed 2026-03-10

What Norris Industries, Inc. reported in its quarterly report filed 2026-03-10 (fiscal Q3 2026): 26 published measures, 85 facts as tagged in accession 0001493152-26-009508.

This filing

Form
10-Q (quarterly report)
Filed
2026-03-10
Fiscal period
fiscal Q3 2026
Accession
0001493152-26-009508 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Norris Industries, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-11-30335,925USD
At 2025-02-28360,335USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-11-304,919,934USD
At 2025-02-284,466,870USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-11-30-5,334,009USD
At 2025-08-31-5,175,832USD
At 2025-05-31-5,023,943USD
At 2025-02-28-4,856,535USD
At 2024-11-30-4,738,315USD
At 2024-08-31-5,970,868USD
At 2024-05-31-5,853,012USD
At 2024-02-29-5,683,975USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-09-01 to 2025-11-30-158,177USD91
2025-03-01 to 2025-11-30-477,474USD275
2025-06-01 to 2025-08-31-151,889USD92
2025-03-01 to 2025-05-31-167,408USD92
2024-09-01 to 2024-11-30-156,461USD91
2024-03-01 to 2024-11-30-443,354USD275
2024-06-01 to 2024-08-31-117,856USD92
2024-03-01 to 2024-05-31-169,037USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-03-01 to 2025-11-30-396,937USD275
2024-03-01 to 2024-11-30-275,254USD275

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2025-09-01 to 2025-11-3054,228USD91
2025-03-01 to 2025-11-30231,386USD275
2024-09-01 to 2024-11-3081,744USD91
2024-03-01 to 2024-11-30259,018USD275

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-03-01 to 2025-11-30400,000USD275
2024-03-01 to 2024-11-30300,000USD275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-11-30-12,351,305USD
At 2025-02-28-11,873,831USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-09-01 to 2025-11-30108,245,688shares91
2025-03-01 to 2025-11-30108,245,688shares275
2024-09-01 to 2024-11-3092,981,797shares91
2024-03-01 to 2024-11-3091,575,004shares275

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-09-01 to 2025-11-30108,245,688shares91
2025-03-01 to 2025-11-30108,245,688shares275
2024-09-01 to 2024-11-3092,981,797shares91
2024-03-01 to 2024-11-3091,575,004shares275

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-09-01 to 2025-11-300USD/shares91
2025-03-01 to 2025-11-300USD/shares275
2024-09-01 to 2024-11-300USD/shares91
2024-03-01 to 2024-11-300USD/shares275

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-09-01 to 2025-11-300USD/shares91
2025-03-01 to 2025-11-300USD/shares275
2024-09-01 to 2024-11-300USD/shares91
2024-03-01 to 2024-11-300USD/shares275

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-09-01 to 2025-11-30-128,133USD91
2025-03-01 to 2025-11-30-391,392USD275
2024-09-01 to 2024-11-30-106,792USD91
2024-03-01 to 2024-11-30-325,299USD275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-11-30144,307USD
At 2025-02-28112,850USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2025-09-01 to 2025-11-3030,044USD91
2025-03-01 to 2025-11-3086,082USD275
2024-09-01 to 2024-11-3049,669USD91
2024-03-01 to 2024-11-30118,055USD275

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-11-30141,459USD
At 2025-02-28126,355USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-11-3055,617USD
At 2025-02-2827,223USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-09-01 to 2025-11-30182,361USD91
2025-03-01 to 2025-11-30622,778USD275
2024-09-01 to 2024-11-30188,536USD91
2024-03-01 to 2024-11-30584,317USD275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-11-30108,245,688shares
At 2025-02-28108,245,688shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-11-306,909,050USD
At 2025-02-286,909,050USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2025-03-01 to 2025-11-30548,828USD275

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2025-03-01 to 2025-11-30-477,474USD275
2024-03-01 to 2025-02-28-561,574USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-09-01 to 2025-11-3016,826USD91
2025-03-01 to 2025-11-30147,837USD275
2024-09-01 to 2024-11-3026,851USD91
2024-03-01 to 2024-11-30130,787USD275

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2025-09-01 to 2025-11-3030,044USD91
2025-03-01 to 2025-11-3086,082USD275
2024-09-01 to 2024-11-3049,669USD91
2024-03-01 to 2024-11-30118,055USD275

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-09-01 to 2025-11-30-30,044USD91
2025-03-01 to 2025-11-30-86,082USD275
2024-09-01 to 2024-11-30-49,669USD91
2024-03-01 to 2024-11-30-118,055USD275

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2025-03-01 to 2025-11-3028,394USD275
2024-03-01 to 2024-11-3014,117USD275

Inspect the source

Entity
Norris Industries, Inc. / CIK 0001603793
Captured
2026-09-20T09:25:41.899Z
SEC response SHA-256
9014b25a4519192bd0f7a1d4d4386d7eeb80ff6185a383177116ae4c5465e831

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001603793.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))